510(k) Report

510(k) · Cleared

Cleared

InnoSEAL Hemostatic Pad

K161013510(k) TraditionalCleared Nov 29, 2016232-day reviewClass U

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Innotherapy, Inc. · QSY Hemostatic Wound Dressing Without Thrombin Or Other Biologics

Cleared on Nov 29, 2016 as substantially equivalent to K032986 (Scion Cardio-Vascular, Inc., 2004) and 1 other predicate after a 232-day review. Its family tree reaches back 6 generations to 1991.

Decided
Nov 29, 2016
Review
232 days
Class
Class U
Product code
QSY
Recalls
None
Predicates
2

Its longest line of descent runs back 6 generations to K914575 (1991). 12 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 6 generations backK914575 Sorbsan Topical Wound Dressing (Modified)Dow B. Hickam, Inc. · 1991
  2. 5 generations backK983210 Algisite MSmith & Nephew, Inc. · 1998
  3. 4 generations backK002896 Acticoat Foam Dressing, Algisite M Calcium Alginate DressingThe Westaim Corp. · 2001
  4. 3 generations backK024298 Antimicrobial Alginate DressingAdvanced Medical Solutions, Ltd. · 2003
  5. 2 generations backK032986 Clo-Surplusp.a.D.Scion Cardio-Vascular, Inc. · 2004
  6. 1 generation backK102944 Coreleader Hemo-Pad Model Cpii 02030Coreleader Biotech Co., Ltd. · 2011
  7. This deviceK161013 InnoSEAL Hemostatic PadInnotherapy, Inc. · 2016
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−6K914575Sorbsan Topical Wound Dressing (Modified)Dow B. Hickam, Inc.1991—
−5K983210Algisite MSmith & Nephew, Inc.1998—
−4K002896Acticoat Foam Dressing, Algisite M Calcium Alginate DressingThe Westaim Corp.2001—
−3K024298Antimicrobial Alginate DressingAdvanced Medical Solutions, Ltd.2003—
−2K032986Clo-Surplusp.a.D.Scion Cardio-Vascular, Inc.2004—
−1K102944Coreleader Hemo-Pad Model Cpii 02030Coreleader Biotech Co., Ltd.2011—
0 (this device)K161013InnoSEAL Hemostatic PadInnotherapy, Inc.2016—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199410
199710
199810
200010
200210
200310
FIG. 1 — Lineage of K161013, 1991–2016Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QSY? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new QSY device

  1. #1 K240713 Traumagel®score 15.0 · 5 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K032986Clo-Surplusp.a.D.
Summary page 5
…Device Class: Unclassified Product Code: FRO (3) PREDICATE DEVICE: Substantial equivalence is based on following legally marketed devices. - Clo-Sur Plus P.A.D (K032986 March 1, 2004) - Coreleader Hemo Pad (K102944 September 7, 2011) The predicates have not been subject to a design-relate…
Scion Cardio-Vascular, Inc.2004—
*K102944Coreleader Hemo-Pad Model Cpii 02030
Summary page 5
…(3) PREDICATE DEVICE: Substantial equivalence is based on following legally marketed devices. - Clo-Sur Plus P.A.D (K032986 March 1, 2004) - Coreleader Hemo Pad (K102944 September 7, 2011) The predicates have not been subject to a design-related recall. No reference devices were used in th…
Coreleader Biotech Co., Ltd.2011—

Also cleared against K032986: 6 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 25 years and passes through 7 companies; a new generation was cleared every 5.2 years on median.
  • 1 of the 12 ancestors has a recall of any class.
  • 6 other devices also cite its predicate K032986.

How does its category compare?

All QSY devices

QSY Hemostatic Wound Dressing Without Thrombin Or Other Biologics: FDA decisions, review times, recalls and adverse event reports over 20 years. 2016, this device’s year, is highlighted.

FDA decisions per year · QSY

2in 2025

2007: 132008: 72009: 92010: 72011: 82012: 72013: 32014: 62015: 62016: 52017: 12018: 52019: 42020: 12021: 12022: 22023: 72024: 42025: 22026 (partial year): 2
2007high 13 (2007) · low 1 (2017)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QSY

142in 2024

2007: 63 days median2008: 61 days median2009: 55 days median2010: 75 days median2011: 137 days median2012: 239 days median2013: 161 days median2014: 249 days median2015: 171 days median2016: 161 days median2018: 186 days median2019: 336 days median2023: 586 days median2024: 142 days median
2007high 586 (2023) · low 55 (2009)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · QSY

No recall names QSY since 2007.

Adverse event reports per year · QSY

14in 2025

2022: 12024: 32025: 14
2007high 14 (2025) · low 0 (2007)2025

MAUDE reports naming product code QSY, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007136300
200876100
200995500
201077500
2011813700
2012723900
2013316100
2014624900
2015617100
2016516100
20171—00
2018518600
2019433600
20201—00
20211—00
20222—01
2023758600
2024414203
20252—014
20262—0—

What is it indicated for?

InnoSEAL Hemostatic Pad is intended for the local management of bleeding wounds and for the promotion of rapid control of bleeding. InnoSEAL Hemostatic Pad is intended for use under the care of a healthcare professional.

The dressing is indicated for following wounds; lacerations, abrasions and the skin surface puncture sites for vascular procedures, percutaneous catheters/tubes.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K161013: InnoSEAL Hemostatic Pad.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K161013

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026